Issue
Med Sci (Paris)
Volume 35, Number 11, Novembre 2019
Nos jeunes pousses ont du talent !
Page(s) 901 - 903
Section Partenariat médecine/sciences - Écoles doctorales - Masters
DOI https://doi.org/10.1051/medsci/2019176
Published online 17 December 2019
  1. Vainchenker W, Kralovics R. Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms. Blood 2017 ; 129 : 667–79. [Google Scholar]
  2. James C, Ugo V, Le Couédic JP, et al. A unique clonal JAK2 mutation leading to constitutive signaling causes polycythaemia vera. Nature 2005 ; 434 : 1144–8. [Google Scholar]
  3. Klampfl T, Gisslinger H, Harutyunyan AS, et al. Somatic mutations of calreticulin in myeloprolifertaive neoplasms. N Engl J Med 2013 ; 369 : 2379–90. [Google Scholar]
  4. Nangalia J, Massie CE, Baxter EJ, et al. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med 2013 ; 369 : 2391–405. [Google Scholar]
  5. Pikman Y, Lee BH, Mercher T, et al. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. PLoS Med 2006 ; 3 : e270. [CrossRef] [PubMed] [Google Scholar]
  6. Marty C, Pecquet C, Nivarthi H, et al. Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis. Blood 2016 ; 127 : 1317–24. [Google Scholar]
  7. Chachoua I, Pecquet C, El-Khoury M, et al. Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants. Blood 2016 ; 127 : 1325–35. [Google Scholar]
  8. Elf S, Abdelfattah NS, Baral AJ, et al. Defining the requirements for the pathogenic interaction between mutant calreticulin and MPL in MPN. Blood 2018 ; 131 : 782–6. [Google Scholar]
  9. Elf S, Abdelfattah NS, Chen E, et al. Mutant calreticulin requires both its mutant C-terminus and the thrombopoietin receptor for oncogenic transformation. Cancer Discov 2016 A ; 6 : 368–81. [CrossRef] [PubMed] [Google Scholar]
  10. Lum R, Ahmad S, Hong SJ, et al. Contributions of the lectin and polypeptide binding sites of calreticulin to its chaperone functions in vitro in cells. J Biol Chem 2016 ; 2 91 : 19631–41. [Google Scholar]
  11. Morita H, Tahara T, Matsumoto A, et al. Functional analysis of the cytoplasmic domain of the human Mpl receptor for tyrosine-phosphorylation of the signaling molecules, proliferation and differentiation. FEBS Lett 1996 ; 395 : 228–34. [CrossRef] [PubMed] [Google Scholar]
  12. Han L, Schubert C, Köhler J, et al. Calreticulin-mutant proteins induce megakaryocytic signaling to transform hematopoietic cells and undergo accelerated degradation and Golgi-mediated secretion. J Hematol Oncol 2016 ; 9 : 45. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.